A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication. It’s the first and ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

When a person with cancer finds out they carry an inherited genetic variant that puts them at higher risk of cancer, the results can help inform their treatment or steps to prevent additional cancer.

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...